VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Buffington Discusses Prostate Cancer Screening

Philip J. Buffington, MD
Published: Thursday, Jan 12, 2017



Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.

Screening for prostate cancer should be done in a smart and efficient way, explains Buffington. Active surveillance has become an important step of determining treatment. Over the last 5 years, the use of active surveillance has increased.

According to Buffington, the amount of procedures a physician completes is not going to be as important as practicing smart medicine, spending a smaller amount of healthcare money, and giving better overall care.



Philip J. Buffington, MD, chief medical officer, The Urology Group, discusses effective prostate cancer screening methods and when to use active surveillance.

Screening for prostate cancer should be done in a smart and efficient way, explains Buffington. Active surveillance has become an important step of determining treatment. Over the last 5 years, the use of active surveillance has increased.

According to Buffington, the amount of procedures a physician completes is not going to be as important as practicing smart medicine, spending a smaller amount of healthcare money, and giving better overall care.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x